A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : ESBLs / extended-spectrum beta-lactamases

[Related PubMed/MEDLINE]
Total Number of Papers: 1339
[Display Entries]
100 entries :
     (Publication year, Descending)
100 entries :
     (Publication year, Ascending)
>> all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   ESBLs  (>> Co-occurring Abbreviation)
Long Form:   extended-spectrum beta-lactamases
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2020 A global multinational survey of cefotaxime-resistant coliforms in urban wastewater treatment plants. CTX-R, WWTPs
2020 A systematic review on the prevalence of extended-spectrum beta lactamase-producing Gram-negative bacteria in Nigeria. AJOL, DDST
2020 Activity of ceftolozane/tazobactam against commonly encountered antimicrobial resistant Gram-negative bacteria in Lebanon. C/T, DD, MDR, MIC
2020 Antibiotic resistance in bacterial isolates from freshwater samples in Fildes Peninsula, King George Island, Antarctica. AMEs, ARGs
2020 Antimicrobial resistance among canine enteric Escherichia coli isolates and prevalence of attaching-effacing and extraintestinal pathogenic virulence factors in Spain. AMR, MDR
2020 Antimicrobial susceptibility and distribution of extended-spectrum beta-lactamases, AmpC beta-lactamases and carbapenemases among Proteus, Providencia and Morganella isolated from global hospitalised patients with intra-abdominal and urinary tract infections: Results of the Study for Monitoring Antimicrobial Resistance Trends (SMART), 2008-2011. SMART
2020 Antimicrobial susceptibility, biofilm formation and genetic profiles of Escherichia coli isolated from retail chicken meat. AMR
2020 Biochemical Characterization of QPX7728, a New Ultrabroad-Spectrum Beta-Lactamase Inhibitor of Serine and Metallo-Beta-Lactamases. BLIs, MBLs
2020 Biogenic Synthesis of ZnO Nanoparticles and Its Potential Use as Antimicrobial Agent Against Multidrug-Resistant Pathogens. MIC, ZnONPs-E
10  2020 Characteristics of Extended-Spectrum beta-Lactamase-Producing Escherichia coli From Dogs and Cats Admitted to a Veterinary Teaching Hospital in Taipei, Taiwan From 2014 to 2017. ---
11  2020 Characterization of beta-lactam resistance in K. pneumoniae associated with ready-to-eat processed meat in Egypt. cKP, HVKP
12  2020 Characterization of Carbapenem-Resistant Enterobacteriaceae Clinical Isolates in Al Thawra University Hospital, Sana'a, Yemen. MLST, PMQR, ST
13  2020 Characterization of ESBL-Producing Enterobacteria from Fruit Bats in an Unprotected Area of Makokou, Gabon. CTX-Ms, SHVs
14  2020 Co-Occurrence of Plasmid-Mediated Colistin Resistance (mcr-1) and Extended-Spectrum beta-Lactamase Encoding Genes in Escherichia coli from Bovine Mastitic Milk in China. ---
15  2020 Comparative genomic analysis reveals high intra-serovar plasticity within Salmonella Napoli isolated in 2005-2017. ARGs, MDR, MLST, S. Napoli, SPIs
16  2020 Detection and Whole-Genome Analysis of a High-Risk Clone of Klebsiella pneumoniae ST340/CG258 Producing CTX-M-15 in a Companion Animal. MDR
17  2020 Detection of multidrug resistance and extended-spectrum/plasmid-mediated AmpC beta-lactamase genes in Enterobacteriaceae isolates from diseased cats in Italy. MDR, pAmpC
18  2020 Dissemination of Multidrug-Resistant and mcr-1 Gram-Negative Bacilli in Broilers, Farm Workers, and the Surrounding Environment in Lebanon. MLST, RT
19  2020 Editorial for the Special Issue: "Targeting beta-Lactamases to Fight Bacterial Resistance to beta-Lactam Antibiotics". ---
20  2020 Emergence of Enteroaggregative Escherichia coli within the ST131 Lineage as a Cause of Extraintestinal Infections. EAEC, ST131, UTIs, WHO
21  2020 Epidemiological characteristics of carbapenem-resistant Enterobacteriaceae collected from 17 hospitals in Nanjing district of China. 16S-RMTase, CRE, MLST, pAmpCs, PBRT, PMQRs, STs
22  2020 Epidemiological Study on Prevalence, Serovar Diversity, Multidrug Resistance, and CTX-M-Type Extended-Spectrum beta-Lactamases of Salmonella spp. from Patients with Diarrhea, Food of Animal Origin, and Pets in Several Provinces of China. MDR, PMQR, QRDR, STs
23  2020 Epidemiology of beta-Lactamase-Producing Pathogens. ---
24  2020 Evaluating the antimicrobial resistance patterns and molecular frequency of bla oxa-48 and bla GES-2 genes in Pseudomonas aeruginosa and Acinetobacter baumannii strains isolated from burn wound infection in Tehran, Iran. ---
25  2020 Evaluation of the performance of Acuitas Resistome Test and the Acuitas Lighthouse software for the detection of beta-lactamase-producing microorganisms. NPV, PCR, PPV
26  2020 Extended-Spectrum beta-Lactamase (ESBL) Genotypes among Multidrug-Resistant Uropathogenic Escherichia coli Clinical Isolates from a Teaching Hospital of Nepal. ESBL, MDR, UTI
27  2020 Extended-spectrum beta-lactamases and plasmid diversity in urinary isolates of Escherichia coli in Croatia: a nation-wide, multicentric, retrospective study. ESC, WGS
28  2020 Fecal Carriage of Extended-Spectrum-beta-Lactamase/AmpC-Producing Escherichia coli in Horses. ESBL, GEE, LB
29  2020 First Indian report on genome-wide comparison of multidrug-resistant Escherichia coli from blood stream infections. AMR, MDR, SNP
30  2020 First Study of Antimicrobial Activity of Ceftazidime-Avibactam and Ceftolozane-Tazobactam Against Pseudomonas aeruginosa Isolated from Patients with Urinary Tract Infection in Tehran, Iran. C/T, CDDT, CZA, MBL, MIC, PCR, PFGE
31  2020 Frequency and molecular epidemiology of class A ESBLs producing Enteroinvasive Escherichia coli (EIEC) isolates among patients with diarrhea. DDST, DEC, EIEC, MLVA
32  2020 Genomic Epidemiology of an Outbreak of Klebsiella pneumoniae ST471 Producing Extended-Spectrum beta-Lactamases in a Neonatal Intensive Care Unit. MCG, NICU, PFGE, ST471, WGS
33  2020 Genomic surveillance for hypervirulence and multi-drug resistance in invasive Klebsiella pneumoniae from South and Southeast Asia. AMR, BSI, STs
34  2020 Genomic surveillance of Escherichia coli ST131 identifies local expansion and serial replacement of subclones. C1_10, C2_8, LTCF, ST131
35  2020 High prevalence of blaCMY AmpC beta-lactamase in ESBL co-producing Escherichia coli and Klebsiella spp. clinical isolates in the northeast of Iran. CDT, E. coli, MDR, PCR
36  2020 High Prevalence of CTX-M Type Extended-Spectrum Beta-Lactamase Genes and Detection of NDM-1 Carbapenemase Gene in Extraintestinal Pathogenic Escherichia coli in Cuba. ExPEC, PMQR
37  2020 In vitro activity of ceftazidime-avibactam and comparators against Gram-negative bacterial isolates collected in the Asia-Pacific region as part of the INFORM program (2015-2017). MBLs, MDR
38  2020 In Vitro Synergistic Effect and Mutant Prevention Concentrations of Cefepime Alone or in Combination with Sulbactam Against OXA-48-positive Klebsiella pneumoniae Isolates. MICs, MPC, TKC
39  2020 Incidence and antimicrobial profile of extended-spectrum beta-lactamase producing gram-negative bacterial isolates: An in-vitro and statistical analysis. ---
40  2020 Intra-abdominal infections among adult intestinal and multivisceral transplant recipients in the 2-year post-operative period. VRE
41  2020 Manila clam (Ruditapes philippinarum) marketed in Korea as a source of vibrios harbouring virulence and beta-lactam resistance genes. ---
43  2020 Molecular Epidemiology of Antimicrobial Resistance of Uropathogenic Escherichia coli Isolates from Patients with Urinary Tract Infections in a Tertiary Teaching Hospital in Iran. ESBL, MLST, STs, UPEC
44  2020 Occurrence of blaTEM and blaCTXM Genes and Biofilm-Forming Ability among Clinical Isolates of Pseudomonas aeruginosa and Acinetobacter baumannii in Yaounde, Cameroon. ACB, AmpC, AST, MBLs, PCR, PSA
45  2020 Pharmacodynamics of Cefepime Combined with the Novel Extended-Spectrum-beta-Lactamase (ESBL) Inhibitor Enmetazobactam for Murine Pneumonia Caused by ESBL-Producing Klebsiella pneumoniae. AUC, ESBL, PK-PD
46  2020 Pharmacokinetic/Pharmacodynamic Determination and Preclinical Pharmacokinetics of the beta-Lactamase Inhibitor ETX1317 and Its Orally Available Prodrug ETX0282. CPDP
47  2020 Pharmacokinetics-Pharmacodynamics of Enmetazobactam Combined with Cefepime in a Neutropenic Murine Thigh Infection Model. PK-PD
48  2020 Prevalence of Extended-Spectrum beta-lactamase and Integron Gene Carriage in Multidrug-Resistant Klebsiella Species Isolated from Outpatients in Yazd, Iran. ESBL, MDR, PCR
49  2020 Prevalence of extended-spectrum beta-lactamases in the local farm environment and livestock: challenges to mitigate antimicrobial resistance. AR, ARMs
50  2020 Prevalence of virulence and extended-spectrum beta-lactamase (ESBL) genes harbouring Vibrio spp. isolated from cockles (Tegillarca granosa) marketed in Korea. ESBL
51  2020 Raw wastewater irrigation for urban agriculture in three African cities increases the abundance of transferable antibiotic resistance genes in soil, including those encoding extended spectrum beta-lactamases (ESBLs). ---
52  2020 Resistance to multiple first-line antibiotics among Escherichia coli from poultry in Western Algeria. MDR
53  2020 Resistance to third-generation cephalosporins in Escherichia coli in the French community: The times they are a-changin'? ---
54  2020 Risk of recurrence in children with a urinary tract infection due to extended-spectrum beta-lactamase producing Enterobacteriaceae. ESBL-PE, UTIs
55  2020 Spread of Klebsiella pneumoniae ST45 Producing GES-5 Carbapenemase or GES-1 Extended-Spectrum beta-Lactamase in Newborns and Infants. ---
56  2020 The determination of gyrA and parC mutations and the prevalence of plasmid-mediated quinolone resistance genes in carbapenem resistant Klebsiella pneumonia ST11 and ST76 strains isolated from patients in Heilongjiang Province, China. CRKP, FQ, FQ-R, MLST, PCR, PFGE, PMQR, QRDR, ST
57  2020 The Inhibitory Effects of Lactobacillus Supernatants and Their Metabolites on the Growth and Biofilm Formation of Klebsiella pneumoniae. SEM, UTI
58  2020 The Phylogenetic Relatedness of bla NDM-1 Harboring Extended-Spectrum beta-Lactamase Producing Uropathogenic Escherichia coli and Klebsiella pneumoniae in the North of Iran. ---
59  2020 Urinary Tract Infections With Extended-spectrum-beta-lactamase-producing Bacteria: Case-control Study. CI, ESBL-PB, ICU, OR, UTI
60  2020 Use of oral third generation cephalosporins and quinolones and occurrence of antibiotic-resistant strains in the neurogenic bladder (NB) outpatient setting: a retrospective chart audit. CFDN, LVFX, NB
61  2020 [Distribution and Drug Sensitivity of Pathogens Causing Nosocomial Infection in Patients with Hematological Granulocytosis]. ---
62  2019 A Case of a Persistent Postoperative Infection Caused by Multidrug-Resistant Kluyvera ascorbata in the Oral and Maxillofacial Region. ---
63  2019 A novel framework to compare the effectiveness of beta-lactamase inhibitors against extended-spectrum beta-lactamase-producing Enterobacteriaceae. ---
64  2019 Activity of Meropenem with a Novel Broader-Spectrum beta-Lactamase Inhibitor, WCK 4234, against Gram-Negative Pathogens Endemic to New York City. KPC
65  2019 An emerging threat of ceftriaxone-resistant non-typhoidal salmonella in South India: Incidence and molecular profile. AMR, NTS
66  2019 Antimicrobial Resistance and Potential Pathogenicity of Escherichia coli Isolates from Healthy Broilers in Quebec, Canada. AMR, MDR
67  2019 Antimicrobial Resistance Factors of Extended-Spectrum Beta-Lactamases Producing Escherichia coli and Klebsiella pneumoniae Isolated from Cattle Farms and Raw Beef in North-West Province, South Africa. ERIC
68  2019 Assessment of extended-spectrum beta-lactamase (ESBLs) - producing Escherichia coli from minced meat of cattle and swab samples and hygienic status of meat retailer shops in Jimma town, Southwest Ethiopia. BPW, DDS, ESBL
69  2019 Azidothymidine Produces Synergistic Activity in Combination with Colistin against Antibiotic-Resistant Enterobacteriaceae. AZT
70  2019 Bacteria Producing Extended Spectrum beta-lactamases (ESBLs) in Hospitalized Patients: Prevalence, Antimicrobial Resistance Pattern and its Main Determinants. UTI
71  2019 Bacterial susceptibility in bloodstream infections: Results from China Antimicrobial Resistance Surveillance Trial (CARST) Program, 2015-2016. CARST, EUCAST, MICs, MRSA, MRSE, VRE
72  2019 Beyond Piperacillin-Tazobactam: Cefepime and AAI101 as a Potent beta-Lactam-beta-Lactamase Inhibitor Combination. ---
73  2019 Biofilm-Forming by Carbapenem Resistant Enterobacteriaceae May Contribute to the Blood Stream Infection. BSI, CRE, MIC, PFGE
74  2019 Cefiderocol: A Siderophore Cephalosporin with Activity Against Carbapenem-Resistant and Multidrug-Resistant Gram-Negative Bacilli. EA, EOT, FUP, KPC, MDR, MITT, TOC
75  2019 Characterization of Antibiotic-Susceptibility Patterns, Virulence Factor Profiles and Clonal Relatedness in Proteus mirabilis Isolates from Patients with Urinary Tract Infection in Iran. CDDT, MDR, PCR, PFGE, PMQR, UTI
76  2019 Characterization of uropathogenic ESBL-producing Escherichia coli isolated from hospitalized patients in western Algeria. ---
77  2019 Clonal dissemination of KPC-2-producing Klebsiella pneumoniae ST11 and ST48 clone among multiple departments in a tertiary teaching hospital in Jiangsu Province, China. CRKP, K. pneumoniae, MLST, PCR, PFGE
78  2019 Clonal relatedness and resistance characteristics of OXA-24 and -58 producing carbapenem-resistant Acinetobacter baumannii isolates in Tehran, Iran. CRAB, MBLs, PFGE
79  2019 Contribution of acrB upregulation & OmpC/Ompk36 loss over the presence of blaNDM towards carbapenem resistance development among pathogenic Escherichia coli & Klebsiella spp. CRE, MBL, MIC, OMP
80  2019 Copan WASPLab automation significantly reduces incubation times and allows earlier culture readings. CI, CPE, MRSA, MSSA
81  2019 Detection of extended-spectrum beta-lactamases producing Enterobacteriaceae using a matrix-assisted laser desorption/ionization time-of-flight mass spectrometry based MBT STAR-BL software module with beta-lactamase inhibition assay depends on the bacterial strains. CTX, CVA, MALDI-TOF MS, SBT
82  2019 Determination of antibiotic resistance genes and virulence factors in Escherichia coli isolated from Turkish patients with urinary tract infection. UTI
83  2019 Development of Broth Microdilution MIC and Disk Diffusion Antimicrobial Susceptibility Test Quality Control Ranges for the Combination of Cefepime and the Novel beta-Lactamase Inhibitor Enmetazobactam. CLSI, QC
84  2019 Diversity in prevalence and characteristics of ESBL/pAmpC producing E. coli in food in Germany. ---
85  2019 Dynamics of clonal and plasmid backgrounds of Enterobacteriaceae producing acquired AmpC in Portuguese clinical settings over time. MLST, PFGE, WGS
86  2019 Effects of low-intensity and low-frequency ultrasound combined with tobramycin on biofilms of extended-spectrum beta-lactamases (ESBLs) Escherichia coli. LILFU
87  2019 Emergence of co-existence of blaNDM with rmtC and qnrB genes in clinical carbapenem-resistant Klebsiella pneumoniae isolates in burning center from southeast of Iran. 16S-RMTase, ERIC
88  2019 Emergence of Enterobacteriaceae co-producing CTX-M-15, ArmA and PMQR in Poland. MIC, MLST, PCR, PFGE, STs
89  2019 Endemic dissemination of different sequence types of carbapenem-resistant Klebsiella pneumoniae strains harboring bla NDM and 16S rRNA methylase genes in Kerman hospitals, Iran, from 2015 to 2017. NDM, STs
90  2019 Epidemiology and antimicrobial susceptibility profiles of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae and Escherichiacoli in China. CLSI
91  2019 Escherichia coli used as a biomarker of antimicrobial resistance in pig farms of Southern Brazil. IRMA
92  2019 Evaluation of biochemical and molecular polymorphism in extended spectrum beta-lactamases of Mycobacterium tuberculosis clinical isolates. IEF, MDR, Mtb, TB
93  2019 Evolution of TEM-type extended-spectrum beta-lactamases in Escherichia coli by cephalosporins. ---
94  2019 Expression of adhesin genes and biofilm formation among Klebsiella oxytoca clinical isolates from patients with antibiotic-associated haemorrhagic colitis. AAHC, MTP
95  2019 Extended-spectrum beta-lactamase production and multi-drug resistance among Enterobacteriaceae isolated in Addis Ababa, Ethiopia. CDT, MDR, MHA
96  2019 First Report of Extended-Spectrum beta-Lactamases TEM-116 and OXA-10 in Clinical Isolates of Alcaligenes Species from Kuala Lumpur, Malaysia. ---
97  2019 First report on extended-spectrum beta-lactamase (ESBL) producing Escherichia coli from European free-tailed bats (Tadarida teniotis) in Portugal: A one-health approach of a hidden contamination problem. ESBL
98  2019 Frequency of infections caused by ESBL-producing bacteria in a pediatric ward - single-center five-year observation. ---
99  2019 Future Challenges in Pediatric and Neonatal Sepsis: Emerging Pathogens and Antimicrobial Resistance. CRE, MDR
100  2019 Genomic and Functional Characterization of Poultry Escherichia coli From India Revealed Diverse Extended-Spectrum beta-Lactamase-Producing Lineages With Shared Virulence Profiles. ---